Your browser doesn't support javascript.
loading
Activation of CD4+ T Cell-Derived Cannabinoid Receptor 2 Signaling Exacerbates Sepsis via Inhibiting IL-10.
Chen, Jincheng; Wang, Fuxiang; Zhang, Su; Lin, Qiao; Xu, Hui; Zhu, Tengfei; Peng, Ling; Cen, Fulan; Li, Fang; Wang, Zhaoqin; Feng, Carl G; Yin, Zhinan; Liu, Yingxia; Zhang, Guoliang.
Afiliación
  • Chen J; National Clinical Research Center for Infectious Diseases, Guangdong Provincial Clinical Research Center for Tuberculosis, The Third People's Hospital of Shenzhen, Southern University of Science and Technology, Shenzhen, China.
  • Wang F; Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China.
  • Zhang S; National Clinical Research Center for Infectious Diseases, Guangdong Provincial Clinical Research Center for Tuberculosis, The Third People's Hospital of Shenzhen, Southern University of Science and Technology, Shenzhen, China.
  • Lin Q; National Clinical Research Center for Infectious Diseases, Guangdong Provincial Clinical Research Center for Tuberculosis, The Third People's Hospital of Shenzhen, Southern University of Science and Technology, Shenzhen, China.
  • Xu H; Department of Traditional Chinese Medicine, The Baoan People's Hospital of Shenzhen, Shenzhen University, Shenzhen, China.
  • Zhu T; National Clinical Research Center for Infectious Diseases, Guangdong Provincial Clinical Research Center for Tuberculosis, The Third People's Hospital of Shenzhen, Southern University of Science and Technology, Shenzhen, China.
  • Peng L; National Clinical Research Center for Infectious Diseases, Guangdong Provincial Clinical Research Center for Tuberculosis, The Third People's Hospital of Shenzhen, Southern University of Science and Technology, Shenzhen, China.
  • Cen F; National Clinical Research Center for Infectious Diseases, Guangdong Provincial Clinical Research Center for Tuberculosis, The Third People's Hospital of Shenzhen, Southern University of Science and Technology, Shenzhen, China.
  • Li F; National Clinical Research Center for Infectious Diseases, Guangdong Provincial Clinical Research Center for Tuberculosis, The Third People's Hospital of Shenzhen, Southern University of Science and Technology, Shenzhen, China.
  • Wang Z; National Clinical Research Center for Infectious Diseases, Guangdong Provincial Clinical Research Center for Tuberculosis, The Third People's Hospital of Shenzhen, Southern University of Science and Technology, Shenzhen, China.
  • Feng CG; National Clinical Research Center for Infectious Diseases, Guangdong Provincial Clinical Research Center for Tuberculosis, The Third People's Hospital of Shenzhen, Southern University of Science and Technology, Shenzhen, China.
  • Yin Z; Infectious, Immunity and Inflammation, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; and.
  • Liu Y; Biomedical Translational Research Institute, Faculty of Medical Science, Jinan University, Guangzhou, China.
  • Zhang G; National Clinical Research Center for Infectious Diseases, Guangdong Provincial Clinical Research Center for Tuberculosis, The Third People's Hospital of Shenzhen, Southern University of Science and Technology, Shenzhen, China; szdsyy@aliyun.com yingxialiu@hotmail.com.
J Immunol ; 208(11): 2515-2522, 2022 06 01.
Article en En | MEDLINE | ID: mdl-35534212
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos T CD4-Positivos / Interleucina-10 / Sepsis / Receptor Cannabinoide CB2 Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Immunol Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos T CD4-Positivos / Interleucina-10 / Sepsis / Receptor Cannabinoide CB2 Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Immunol Año: 2022 Tipo del documento: Article País de afiliación: China